Table 5.
Summary of Subtypes and Etiologies of Leukocytoclastic Vasculitis
Subtype | No. (%) |
---|---|
Palpable purpura (predominant) | |
CSVV (n=38) | |
Idiopathic | 29 (76) |
ACTDa | 2 (5) |
Infectionb | 6 (16) |
Drug reactionc | 1 (3) |
IgA vasculitis (n=25) | |
Idiopathic | 24 (96) |
Infectiond | 1 (4) |
ANCA-associated vasculitis (n=8) | |
Microscopic polyangiitis | 1 (12.5) |
Granulomatosis with polyangiitis | 2 (25) |
Eosinophilic granulomatosis with polyangiitis | 2 (25) |
p-ANCA, NOS | 2 (25) |
c-ANCA, NOS | 1 (12.5) |
Cryoglobulinemic vasculitis (n=3) | |
ACTDe | 1 (33) |
Infectionf | 2 (67) |
Urticaria-like lesions | |
Urticarial vasculitis (n=10) | |
Normocomplementemic | 8 (80)g |
Idiopathic | 6 (75) |
Infectionh | 1(12.5) |
Drug reactioni | 1 (12.5) |
Hypocomplementemic | 2 (20) |
ACTDj | 2 (100) |
Abbreviations: ACTD, autoimmune connective tissue disease; ANCA, antineutrophil cytoplasmic antibody; c-ANCA, cytoplasmic ANCA; CSVV, cutaneous small-vessel vasculitis; NOS, not otherwise specified; p-ANCA, perinuclear ANCA.
Sjögren syndrome and systemic lupus erythematosus in 1 patient each.
Hepatitis C in 2 patients and hepatitis B and C, parvovirus, pneumonia, and streptococcal infection in 1 patient each.
Amoxicillin.
Streptococcal infection.
Rheumatoid arthritis.
Hepatitis C.
Complements were not checked in 2 patients.
Hepatitis C.
Epoetin alfa.
Systemic lupus erythematosus and mixed connective tissue disease in 1 patient each.